stocksbrew

Sellas Life Sciences Group Inc.SLS

Buy more

Buy more on a dip to our buy price, which is under today's $8.09.

  • 2 good· Above 200-day
  • 2 to watch· Below 50-day

$8.09−0.33 (−3.92%)

Price at 3:03 PM ET

After hours · opens in 17h 24mNext open: Friday, Nov 13, 9:30 AM ET

NASDAQ · Healthcare · Small company

The price we'd buy SLS at comes with a free account

It also has the whole brief, the scorecard and how the call has moved.A free account gets it on three stocks you pick, plus three long research reports a month.

What would change it

Sources
  • Yahoo Finance daily closes to Nov 10

Any one could move it to Keep

Compared with the S&P 500

  • 24 points

    worse in one day

  • 54 points

    worse in five trading days

+439% in a year

Earnings report

The news behind our call

written 9:58 AM ET9:58 AM ET · 2 articles · 2 sources
  • SELLAS Life Sciences reported on Nov 11.

  • SELLAS has strong projected earnings growth.

  • Analysts currently favor SELLAS.

What changed

From Sellas Life Sciences Group Inc. via Yahoo Finance, IOVA via Yahoo Finance, Yahoo Finance Australia and 3 more

SELLAS ended the reported session modestly higher, but the print provided limited incremental fundamental information.

  1. SELLAS Life Sciences Group, Inc. (SLS) stock price, news, Quote & History

    Today

  2. CAPR vs IBRX vs SLS vs IOVA: Whose Insiders Cashed out the most — and who bought before a 5X surge?

    Today

  3. SELLAS ended the reported session modestly higher, but the print provided limited incremental fundamental information.

    Reported EPS was not captured, and no EPS estimate was available; therefore, no beat or miss can be established. No company guidance or updated outlook was provided in the available data.

    Earnings · Yesterday

  4. SELLAS Life Sciences Group, Inc. (SLS) stock price, news, quote and history

    Yesterday

  5. SLS stock rises after-hours: State Street reveals over 5% stake — and one fund Manager Boosted Holdings by nearly 1,000%

    Tuesday

  6. Barclays, Deutsche Bank Reveal Stakes in Retail-Favorite Cancer stocks SLS, IBRX and IOVA — Geode adds more

    Monday

  7. SLS stock hits over 1-month low: Retail bulls Double down before Cancer data — Fresh Filings Show Q3 stake hikes of over 400%

    Nov 2

  8. SLS Dec 2026 16.500 call (SLS261211C00016500) stock price, news, quote and history

    Nov 2

Financials

Revenue fell 87% between FY 2021 and FY 2022, to $1.0M. It burned $28.4M of free cash in the last twelve months.

Revenue

$ · latest 1.0M

Net income

Still a lossFY25 vs FY24$ · latest −32.5M

EPS (diluted)

Still a lossFY25 vs FY24$ per share · latest -0.21

Free cash flow

$ · latest −28.4M

Margins

% of revenue
Gross90%Operating-3195%Net-4130%

Cash and debt

latest balance sheet
  • Cash and investments$138M
  • Total debt$740K

It holds $138.3M in cash and investments against $740,000 of debt, which leaves $137.6M of net cash.

Key facts

Company value
$1.7B
Today's range
8.018.40
Past year's range
1.3915.46
Yesterday's close
$8.42
Swings vs the market
2.4×bigger
After hours

That's a wrap.

17hrs24min03sec

Market opens Friday, Nov 13 at 9:30 AM ET